• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性髓系白血病中耐黏菌素和碳青霉烯类药物相关坏疽性脓皮病的成功管理:一种罕见并发症。

Successful management of colistin- and carbapenem-resistant -associated ecthyma gangrenosum in acute myeloid leukemia: A rare complication.

作者信息

Jamal Aisha, Saleem Ali, Rezwan Faiza, Sheikh Affaf, Shamsi Tahir

机构信息

Department of Clinical Haematology, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.

Department of Research & Development, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.

出版信息

SAGE Open Med Case Rep. 2022 May 25;10:2050313X221102113. doi: 10.1177/2050313X221102113. eCollection 2022.

DOI:10.1177/2050313X221102113
PMID:35655712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9152185/
Abstract

Pseudomonal ecthyma gangrenosum is a well-known condition in immunosuppressed patients. However, ecthyma gangrenosum associated with is a rare entity that requires early recognition and optimal antibiotic and surgical management. We herein report the first case of colistin & carbapenem-resistant ecthyma gangrenosum in an acute myeloid leukemia patient. A 30-year-old female with acute myeloid leukemia received induction chemotherapy at the National Institute of Blood Diseases and Bone Marrow Transplantation hospital. Post-chemotherapy, she developed fever and a necrotic erythematous papule on right forearm. Colistin-susceptible carbapenem-resistant was isolated in cultures. Susceptibility testing was performed by microbroth dilution method. Worsening necrotic lesion prompted surgical debridement. Histopathology of debrided tissue revealed necrotic inflammation, and tissue cultures grew colistin-resistant carbapenem-resistant (colistin minimum inhibitory concentration >4 µg/mL). We speculate that colistin resistance was acquired due to impaired antibiotic penetration in necrotic nidus. A higher incidence of carbapenem-resistant associated ecthyma gangrenosum is anticipated in hem-oncology patients, and timely diagnosis, appropriate antibiotics, and surgical debridement remain the only potential cure.

摘要

铜绿假单胞菌坏疽性脓皮病在免疫抑制患者中是一种众所周知的病症。然而,与[此处原文缺失相关内容]相关的坏疽性脓皮病是一种罕见的情况,需要早期识别以及最佳的抗生素和手术治疗。我们在此报告了首例急性髓系白血病患者发生的对黏菌素和碳青霉烯耐药的铜绿假单胞菌坏疽性脓皮病。一名30岁的急性髓系白血病女性患者在国家血液疾病和骨髓移植医院接受诱导化疗。化疗后,她出现发热,右前臂出现坏死性红斑丘疹。培养物中分离出对黏菌素敏感但对碳青霉烯耐药的铜绿假单胞菌。通过微量肉汤稀释法进行药敏试验。坏死病变的恶化促使进行手术清创。清创组织的组织病理学显示坏死性炎症,组织培养物中生长出对黏菌素耐药且对碳青霉烯耐药的铜绿假单胞菌(黏菌素最低抑菌浓度>4μg/mL)。我们推测黏菌素耐药是由于抗生素在坏死病灶中渗透受损所致。预计血液肿瘤患者中耐碳青霉烯类相关坏疽性脓皮病的发病率会更高,及时诊断、使用合适的抗生素和手术清创仍然是唯一可能的治愈方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff0/9152185/e6d635b68713/10.1177_2050313X221102113-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff0/9152185/3edd01c1d9ab/10.1177_2050313X221102113-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff0/9152185/a6b198e58c1a/10.1177_2050313X221102113-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff0/9152185/e6d635b68713/10.1177_2050313X221102113-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff0/9152185/3edd01c1d9ab/10.1177_2050313X221102113-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff0/9152185/a6b198e58c1a/10.1177_2050313X221102113-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fff0/9152185/e6d635b68713/10.1177_2050313X221102113-fig3.jpg

相似文献

1
Successful management of colistin- and carbapenem-resistant -associated ecthyma gangrenosum in acute myeloid leukemia: A rare complication.急性髓系白血病中耐黏菌素和碳青霉烯类药物相关坏疽性脓皮病的成功管理:一种罕见并发症。
SAGE Open Med Case Rep. 2022 May 25;10:2050313X221102113. doi: 10.1177/2050313X221102113. eCollection 2022.
2
[In Vitro Activity of Ceftazidime-avibactam and Colistin Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates].头孢他啶-阿维巴坦与黏菌素对耐碳青霉烯类肺炎克雷伯菌临床分离株的体外活性
Mikrobiyol Bul. 2022 Apr;56(2):218-229. doi: 10.5578/mb.20229803.
3
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.一名年轻成人患耐碳青霉烯类肺炎克雷伯菌心内膜炎。庆大霉素和黏菌素治疗成功。
Int J Infect Dis. 2009 Sep;13(5):e295-8. doi: 10.1016/j.ijid.2009.01.006. Epub 2009 Mar 28.
4
Inactivation of mgrB gene regulator and resistance to colistin is becoming endemic in carbapenem-resistant Klebsiella pneumoniae in Greece: A nationwide study from 2014 to 2017.在希腊,耐碳青霉烯类肺炎克雷伯菌中 mgrB 基因调控因子失活和对黏菌素耐药现象呈地方性流行:2014 年至 2017 年的全国性研究。
Int J Antimicrob Agents. 2020 Apr;55(4):105930. doi: 10.1016/j.ijantimicag.2020.105930. Epub 2020 Mar 1.
5
Evaluation of ComASP™ Colistin (formerly SensiTest™ Colistin), a commercial broth microdilution-based method to evaluate the colistin minimum inhibitory concentration for carbapenem-resistant Klebsiella pneumoniae isolates.评价 ComASP™ 多粘菌素(前称 SensiTest™ 多粘菌素),一种商业化的肉汤微量稀释法,用于评估碳青霉烯类耐药肺炎克雷伯菌分离株的多粘菌素最小抑菌浓度。
J Glob Antimicrob Resist. 2018 Dec;15:123-126. doi: 10.1016/j.jgar.2018.07.006. Epub 2018 Jul 20.
6
Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.密歇根州底特律大都市爆发多粘菌素耐药、碳青霉烯类耐药肺炎克雷伯菌。
Antimicrob Agents Chemother. 2011 Feb;55(2):593-9. doi: 10.1128/AAC.01020-10. Epub 2010 Nov 29.
7
Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend.鲍曼不动杆菌、铜绿假单胞菌和肺炎克雷伯菌引起的碳青霉烯类和多黏菌素耐药菌血症的流行率和 30 天全因死亡率:长达十年趋势的描述。
Int J Infect Dis. 2019 Aug;85:10-15. doi: 10.1016/j.ijid.2019.05.004. Epub 2019 May 14.
8
Successful Use of Negative-pressure Wound Therapy and Dermal Substitute in the Treatment of Gluteal Ecthyma Gangrenosum in a 2-year-old Girl.负压伤口治疗和真皮替代物成功用于治疗一名2岁女童的臀部坏疽性臁疮
Plast Reconstr Surg Glob Open. 2018 Oct 3;6(10):e1953. doi: 10.1097/GOX.0000000000001953. eCollection 2018 Oct.
9
Investigation of the Relationship between Colistin Resistance and Capsule Serotypes in Carbapenem Resistant Klebsiella pneumoniae Strains.碳青霉烯类耐药肺炎克雷伯菌中黏菌素耐药与荚膜血清型关系的研究。
New Microbiol. 2022 Apr;45(2):124-129.
10
Carbapenem-Resistant Exhibiting Clinically Undetected Colistin Heteroresistance Leads to Treatment Failure in a Murine Model of Infection.碳青霉烯类耐药但临床检测不出的多粘菌素异质性耐药导致感染的小鼠模型治疗失败。
mBio. 2018 Mar 6;9(2):e02448-17. doi: 10.1128/mBio.02448-17.

本文引用的文献

1
Treatment Options for Colistin Resistant : Present and Future.耐黏菌素的治疗选择:现状与未来
J Clin Med. 2019 Jun 28;8(7):934. doi: 10.3390/jcm8070934.
2
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.ESCMID-EUCIC 临床指南:多重耐药革兰氏阴性菌携带者的去定植化。
Clin Microbiol Infect. 2019 Jul;25(7):807-817. doi: 10.1016/j.cmi.2019.01.005. Epub 2019 Jan 29.
3
Ecthyma gangrenosum caused by Klebsiella pneumoniae and Streptococcus vestibularis in a patient with acute myeloid leukemia: an emerging pathogen.
一名急性髓系白血病患者中由肺炎克雷伯菌和前庭链球菌引起的坏疽性脓皮病:一种新出现的病原体。
Int J Dermatol. 2019 Apr;58(4):E83-E85. doi: 10.1111/ijd.14322. Epub 2018 Dec 12.
4
Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae.产新德里金属β-内酰胺酶(NDM)肺炎克雷伯菌中新型可移动黏菌素耐药基因 mcr-8 的出现。
Emerg Microbes Infect. 2018 Jul 4;7(1):122. doi: 10.1038/s41426-018-0124-z.
5
Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review.成人造血干细胞移植受者早期抗菌药物降阶梯与管理:回顾性研究
Open Forum Infect Dis. 2017 Dec 11;4(4):ofx226. doi: 10.1093/ofid/ofx226. eCollection 2017 Fall.
6
Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study.中国患者和健康成年人中产 mcr-1 阳性肠杆菌科细菌的流行情况、危险因素、结局和分子流行病学:一项流行病学和临床研究。
Lancet Infect Dis. 2017 Apr;17(4):390-399. doi: 10.1016/S1473-3099(16)30527-8. Epub 2017 Jan 28.
7
Combatting antimicrobial resistance globally.全球抗击抗菌药物耐药性
Nat Microbiol. 2016 Sep 27;1(10):16187. doi: 10.1038/nmicrobiol.2016.187.
8
Ecthyma gangrenosum versus ecthyma-like lesions: should we separate these conditions?坏疽性臁疮与臁疮样损害:我们应该区分这些情况吗?
Acta Dermatovenerol Alp Pannonica Adriat. 2015;24(4):69-72. doi: 10.15570/actaapa.2015.18.
9
Ecthyma gangrenosum and ecthyma-like lesions: review article.坏疽性脓皮病及类坏疽性损害:综述文章
Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):633-9. doi: 10.1007/s10096-014-2277-6. Epub 2014 Nov 19.
10
In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.产KPC的肺炎克雷伯菌中PmrB传感器激酶突变导致对黏菌素耐药的体内进化与低剂量黏菌素治疗有关。
Antimicrob Agents Chemother. 2014 Aug;58(8):4399-403. doi: 10.1128/AAC.02555-14. Epub 2014 May 19.